calendar
7,476 catalysts · 3,301 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k
next 91 dayslessmore
MonWedFri
7,476 catalysts · 3,301 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k
Supplement type: Normal 180 Day Track No User Fee. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: 135 Review Track For 30-Day Notice. Product code: LZD. Advisory committee: DE. Decision: APPR
Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: QTL. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: NKM. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LOF. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: NIK. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LWP. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: QZI. Advisory committee: CV. Decision: OK30
DC grant. $216,612. PI: Lisa M Hamrick
NS grant. $15,000. PI: Theresa Marie Desrochers
NS grant. $479,687. PI: Melissa Leigh Barker-Haliski
DK grant. $759,944. PI: Aaron S Kelly
NS grant. $214,101. PI: Jordina Rincon Torroella
NS grant. $654,628. PI: Russell Patrick Sawyer
NS grant. $556,686. PI: Jarred W. Younger
NS grant. $562,051. PI: SOPHIE BELIN
HL grant. $49,866. PI: Caroline Sands
DK grant. $825,905. PI: Nancy L. Allbritton
DE grant. $23,000. PI: Samantha A Brugmann
GM grant. $398,464. PI: Michael Pluth
GM grant. $446,875. PI: Natali L Chanaday Ricagni
GM grant. $429,000. PI: Yang Liu
GM grant. $423,500. PI: Tino Pleiner
HG grant. $2,114,800. PI: Kenneth M. Rice
NS grant. $126,900. PI: Brian Jude Joseph
Product code: OLZ. Advisory committee: Neurology. Type: Traditional
Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL
Sponsor: APOTEX. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: MICRO LABS. Form: TABLET. Route: ORAL
Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION
Sponsor: CONTRACT PHARMACAL. Form: FOR SUSPENSION. Route: ORAL
Sponsor: E5 PHARMA. Form: TABLET. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Sponsor: KNACK. Form: INJECTABLE. Route: INJECTION
Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL
Product code: HRS. Advisory committee: Orthopedic. Type: Traditional
Product code: FDT. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Traditional
Product code: NFT. Advisory committee: Clinical Toxicology. Type: Traditional
Product code: PDZ. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: MBH. Advisory committee: Orthopedic. Type: Traditional
Product code: PBX. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: PCH. Advisory committee: Microbiology. Type: Traditional
Product code: MBI. Advisory committee: Orthopedic. Type: Special
Product code: LNH. Advisory committee: Radiology. Type: Traditional
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: APPR
Supplement type: 135 Review Track For 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: APPR